Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,961.50p on 10-07-2026 at 18:35:09
Change 2.00p 0.1%
Buy 1,960.50p
Sell 1,959.50p
Last Trade: Buy 171.00 at 1,961.50p
Day's Volume: 6,365,614
Last Close: 1,961.50p
Open: 1,963.50p
ISIN: GB00BN7SWP63
Day's Range 1,954.00p - 1,981.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £78.57b
VWAP: 1,963.84104p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 171 1,961.50p SI Trade
Negotiated Trade
16:52:49 - 10-Jul-26
Buy* 1,703 1,968.732p SI Trade
Negotiated Trade
16:47:05 - 10-Jul-26
Unknown* 4,324 1,961.50p OTC Trade
16:38:00 - 10-Jul-26
Buy* 960 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 800 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 900 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 2,165 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 400 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 400 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
Buy* 200 1,961.50p Automatic Execution
16:35:41 - 10-Jul-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
10th Jul 2026 (Fri) 1,963.50 1,981.00 1,954.00 1,961.50 6,365,614
9th Jul 2026 (Thu) 1,960.00 1,982.50 1,951.00 1,959.50 5,592,231
8th Jul 2026 (Wed) 1,990.50 1,990.50 1,964.00 1,979.50 4,243,160
7th Jul 2026 (Tue) 1,998.00 2,031.00 1,982.00 2,003.00 4,183,205
6th Jul 2026 (Mon) 2,025.00 2,048.00 1,967.50 1,983.00 15,157,640
3rd Jul 2026 (Fri) 2,005.00 2,015.00 1,988.00 2,015.00 2,548,103
2nd Jul 2026 (Thu) 1,949.00 2,014.00 1,943.00 2,004.00 17,566,583
1st Jul 2026 (Wed) 1,981.00 1,992.00 1,930.00 1,930.00 8,817,916
30th Jun 2026 (Tue) 1,999.50 2,009.00 1,946.50 1,981.00 13,957,667
29th Jun 2026 (Mon) 1,995.00 1,996.50 1,969.00 1,979.50 9,717,943
26th Jun 2026 (Fri) 1,972.50 1,995.50 1,945.50 1,983.00 13,837,274
25th Jun 2026 (Thu) 1,949.00 1,991.00 1,926.50 1,983.50 8,999,065
24th Jun 2026 (Wed) 1,967.00 1,984.00 1,950.00 1,950.00 5,923,852
23rd Jun 2026 (Tue) 1,915.00 1,971.00 1,911.00 1,957.50 8,305,282
22nd Jun 2026 (Mon) 1,925.00 1,931.50 1,912.00 1,924.50 3,565,700
19th Jun 2026 (Fri) 1,926.00 1,943.00 1,917.00 1,925.50 15,135,955
18th Jun 2026 (Thu) 1,976.00 1,978.50 1,906.00 1,923.00 7,565,324
17th Jun 2026 (Wed) 1,948.50 1,974.00 1,935.50 1,972.50 4,713,165
16th Jun 2026 (Tue) 1,955.50 1,968.00 1,940.50 1,950.00 6,759,168
15th Jun 2026 (Mon) 1,984.00 1,988.50 1,953.50 1,958.00 7,052,610
12th Jun 2026 (Fri) 1,963.50 2,011.00 1,960.00 1,984.00 5,538,575
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
10th Jul 2026 11:58 am RNS Hansoh positive Phase III results for Riz-Rez
9th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
9th Jul 2026 10:00 am RNS Directorate change
1st Jul 2026 3:00 pm RNS Total Voting Rights
29th Jun 2026 3:00 pm RNS Transaction in Own Shares
29th Jun 2026 3:00 pm RNS Holding(s) in Company
26th Jun 2026 3:00 pm RNS Holding(s) in Company
24th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
24th Jun 2026 2:52 pm RNS GSK announces tender offer to acquire Nuvalent
23rd Jun 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

10th Jul 2026 13:11

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or relapsed small-cell lung cancer. Read More

GSK adds Royal Philips' Chief Executive Jakobs to board

9th Jul 2026 11:01

(Alliance News) - GSK PLC on Thursday announced that Roy Jakobs, the chief executive officer of Royal Philips NV, will join its board next week as a non-executive director. Read More

LONDON BROKER RATINGS: Computacenter gets two price target hikes

9th Jul 2026 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET CLOSE: Stocks mixed as weak miners weigh in muted trade

6th Jul 2026 17:07

(Alliance News) - The FTSE 100 gave back early gains on Monday as falls in gold miners and AstraZeneca, plus soft construction figures, dampened early enthusiasm. Read More

LONDON BROKER RATINGS: HSBC raises GSK; RBC cuts Close Brothers

6th Jul 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday : Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,497.29
Change24.84

Login to your account

Forgot Password?

Not Registered